| Dr Andrew David Samel, MD | |
|
152 Emory St, Attleboro, MA 02703-2434 | |
| (508) 226-0400 | |
| (508) 226-3301 |
| Full Name | Dr Andrew David Samel |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 38 Years |
| Location | 152 Emory St, Attleboro, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821066291 | NPI | - | NPPES |
| 3095207 | Medicaid | MA | |
| 076041 | Other | MA | TUFTS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 76041 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sturdy Memorial Hospital | Attleboro, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Attleboro Dermatology Pc | 1658315411 | 2 |
News Archive
Boston University researchers have developed a new, "intelligent" metamaterial-which costs less than ten bucks to build-that could revolutionize magnetic resonance imaging, making the entire MRI process faster, safer, and more accessible to patients around the world.
Mobile health apps are a booming market targeted at both patients and health professionals. Medicines-related apps help patients track their prescriptions and remember to take their pills.
With the number of global cancer cases expected to increase by more than 50 percent by 2030, researchers around the globe have collaborated to create a new tool for global leaders to determine what actions they must take to better control cancer.
The US National Institutes of Health (NIH) has awarded a $2.1 million "Grand Opportunity" (GO) grant to a team of researchers - led by Prof. Todd Lencz at the Feinstein Institute for Medical Research, New York, and Prof.Ariel Darvasi of the Silberman Institute of Life Sciences at the Hebrew University of Jerusalem - to conduct a study on the genetic basis of schizophrenia..
› Verified 5 days ago
| Entity Name | Attleboro Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811965296 PECOS PAC ID: 1658315411 Enrollment ID: O20050614000199 |
News Archive
Boston University researchers have developed a new, "intelligent" metamaterial-which costs less than ten bucks to build-that could revolutionize magnetic resonance imaging, making the entire MRI process faster, safer, and more accessible to patients around the world.
Mobile health apps are a booming market targeted at both patients and health professionals. Medicines-related apps help patients track their prescriptions and remember to take their pills.
With the number of global cancer cases expected to increase by more than 50 percent by 2030, researchers around the globe have collaborated to create a new tool for global leaders to determine what actions they must take to better control cancer.
The US National Institutes of Health (NIH) has awarded a $2.1 million "Grand Opportunity" (GO) grant to a team of researchers - led by Prof. Todd Lencz at the Feinstein Institute for Medical Research, New York, and Prof.Ariel Darvasi of the Silberman Institute of Life Sciences at the Hebrew University of Jerusalem - to conduct a study on the genetic basis of schizophrenia..
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew David Samel, MD 152 Emory St, Attleboro, MA 02703-2434 Ph: (508) 226-0400 | Dr Andrew David Samel, MD 152 Emory St, Attleboro, MA 02703-2434 Ph: (508) 226-0400 |
News Archive
Boston University researchers have developed a new, "intelligent" metamaterial-which costs less than ten bucks to build-that could revolutionize magnetic resonance imaging, making the entire MRI process faster, safer, and more accessible to patients around the world.
Mobile health apps are a booming market targeted at both patients and health professionals. Medicines-related apps help patients track their prescriptions and remember to take their pills.
With the number of global cancer cases expected to increase by more than 50 percent by 2030, researchers around the globe have collaborated to create a new tool for global leaders to determine what actions they must take to better control cancer.
The US National Institutes of Health (NIH) has awarded a $2.1 million "Grand Opportunity" (GO) grant to a team of researchers - led by Prof. Todd Lencz at the Feinstein Institute for Medical Research, New York, and Prof.Ariel Darvasi of the Silberman Institute of Life Sciences at the Hebrew University of Jerusalem - to conduct a study on the genetic basis of schizophrenia..
› Verified 5 days ago
Yvonne C Hines, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 555 Pleasant St, Suite 106, Attleboro, MA 02703 Phone: 508-222-1976 Fax: 508-226-9619 |